Filing Details
- Accession Number:
- 0001708138-21-000081
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-15 16:03:12
- Reporting Period:
- 2021-09-13
- Accepted Time:
- 2021-09-15 16:03:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1681643 | Y Huda Zoghbi | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-13 | 2 | $391.92 | 893 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-09-13 | 2 | $651.10 | 891 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-09-14 | 998 | $391.92 | 1,889 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-09-14 | 998 | $650.00 | 891 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-09-13 | 2 | $0.00 | 2 | $391.92 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-09-14 | 998 | $0.00 | 998 | $391.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,115 | 2026-09-09 | No | 4 | M | Direct | |
| 4,117 | 2026-09-09 | No | 4 | M | Direct |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
